Skip to main content

Volume 16, Issue 4, April 2019 - First Report Managed Care

Featured Article

04/19/2019
Donald Rucker, MD, discusses progress in the areas of interoperability, reducing provider burden, and giving patients more control of their health data, as well as suggests how managed care stakeholders can position themselves for success as...
Donald Rucker, MD, discusses progress in the areas of interoperability, reducing provider burden, and giving patients more control of their health data, as well as suggests how managed care stakeholders can position themselves for success as...
Donald Rucker, MD, discusses...
04/19/2019
First Report Managed Care
04/19/2019
As the federal government moves toward adopting and expanding value-based payment models, private market providers and payers are striving to smoothly transition to the new models, furthering the transformation of thought and practice of how...
As the federal government moves toward adopting and expanding value-based payment models, private market providers and payers are striving to smoothly transition to the new models, furthering the transformation of thought and practice of how...
As the federal government moves...
04/19/2019
First Report Managed Care
04/19/2019
Millennials and members of Generation Z are more dissatisfied than their older counterparts with some aspects of traditional health care. Here’s how these younger adults and their expectations are shaping the current and future managed care...
Millennials and members of Generation Z are more dissatisfied than their older counterparts with some aspects of traditional health care. Here’s how these younger adults and their expectations are shaping the current and future managed care...
Millennials and members of...
04/19/2019
First Report Managed Care
04/19/2019
Could medication with built-in digital sensors improve medication adherence and reduce health care costs? Experts discuss the potential benefits of novel digital medicines against privacy concerns of large-scale data collection.
Could medication with built-in digital sensors improve medication adherence and reduce health care costs? Experts discuss the potential benefits of novel digital medicines against privacy concerns of large-scale data collection.
Could medication with built-in...
04/19/2019
First Report Managed Care

Department

Formulary Frontlines®
04/19/2019
Asthma is a condition of hypersensitivity to common exposures associated with chronic airway inflammation, bronchial hyperreactivity with increased mucus and airway edema, obstruction, and narrowing. Barbara Yawn, MD, MSc, FAFFP, outlines...
Asthma is a condition of hypersensitivity to common exposures associated with chronic airway inflammation, bronchial hyperreactivity with increased mucus and airway edema, obstruction, and narrowing. Barbara Yawn, MD, MSc, FAFFP, outlines...
Asthma is a condition of...
04/19/2019
First Report Managed Care
Managed Care Q&A
04/19/2019
Research economist, Katalin Bognar, PhD, Precision Health Economics, discusses the benefits of the use of rapid, cloud-enabled, onsite testing for rheumatoid arthritis.
Research economist, Katalin Bognar, PhD, Precision Health Economics, discusses the benefits of the use of rapid, cloud-enabled, onsite testing for rheumatoid arthritis.
Research economist, Katalin...
04/19/2019
First Report Managed Care
News Connection
04/19/2019
Between 2016 and 2017, the national utilization of telehealth as a service grew 53%, according to data from a recent white paper outlining service trends and medical pricing published by FAIR Health.
Between 2016 and 2017, the national utilization of telehealth as a service grew 53%, according to data from a recent white paper outlining service trends and medical pricing published by FAIR Health.
Between 2016 and 2017, the...
04/19/2019
First Report Managed Care
News Connection
04/19/2019
Johnson & Johnson announced the US Federal Drug Administration approved the new, ketamine-like, nasal spray depression treatment, Spravato (esketamine). The pharmaceutical company confirmed that Spravato, will be priced at $590 for a 56mg...
Johnson & Johnson announced the US Federal Drug Administration approved the new, ketamine-like, nasal spray depression treatment, Spravato (esketamine). The pharmaceutical company confirmed that Spravato, will be priced at $590 for a 56mg...
Johnson & Johnson announced the...
04/19/2019
First Report Managed Care
News Connection
04/19/2019
Although most insurers tend to cover physical and occupational therapy as well as chiropractic care for the treatment of chronic low back pain, coverage for acupuncture and psychological interventions is less consistent despite evidence...
Although most insurers tend to cover physical and occupational therapy as well as chiropractic care for the treatment of chronic low back pain, coverage for acupuncture and psychological interventions is less consistent despite evidence...
Although most insurers tend to...
04/19/2019
First Report Managed Care
News Connection
04/19/2019
The Department of Veterans Affairs (VA) recently announced that its health care providers will be able to offer veterans the newly approved nasal spray for treatment-resistant depression. 
The Department of Veterans Affairs (VA) recently announced that its health care providers will be able to offer veterans the newly approved nasal spray for treatment-resistant depression. 
The Department of Veterans...
04/19/2019
First Report Managed Care
News Connection
04/19/2019
A recent study revealed that engaged employees within the Department of Veteran Affairs (VA) medical centers had higher patient satisfaction, better call center performance, and lower turnover among registered nurses.
A recent study revealed that engaged employees within the Department of Veteran Affairs (VA) medical centers had higher patient satisfaction, better call center performance, and lower turnover among registered nurses.
A recent study revealed that...
04/19/2019
First Report Managed Care